Fojo T - Search Results

1

Is there room for improvement in adverse event reporting in the era of targeted therapies?

Edgerly M, Fojo T. Edgerly M, et al. Among authors: fojo t. J Natl Cancer Inst. 2008 Feb 20;100(4):240-2. doi: 10.1093/jnci/djm324. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270340

2

Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.

Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC. Agrawal M, et al. Among authors: fojo t. Clin Cancer Res. 2003 Feb;9(2):650-6. Clin Cancer Res. 2003. PMID: 12576431 Clinical Trial.

3

Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog.

Agrawal M, Edgerly M, Fojo T, Kotz H. Agrawal M, et al. Among authors: fojo t. Gynecol Oncol. 2003 Jul;90(1):96-9. doi: 10.1016/s0090-8258(03)00146-x. Gynecol Oncol. 2003. PMID: 12821348

4

A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days.

Zhuang SH, Agrawal M, Edgerly M, Bakke S, Kotz H, Thambi P, Rutt A, Balis FM, Bates S, Fojo T. Zhuang SH, et al. Among authors: fojo t. Cancer. 2005 May 1;103(9):1932-8. doi: 10.1002/cncr.20977. Cancer. 2005. PMID: 15800893 Free article. Clinical Trial.

5

A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.

Huang H, Menefee M, Edgerly M, Zhuang S, Kotz H, Poruchynsky M, Huff LM, Bates S, Fojo T. Huang H, et al. Among authors: fojo t. Clin Cancer Res. 2010 Mar 1;16(5):1634-41. doi: 10.1158/1078-0432.CCR-09-0379. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179242 Free PMC article. Clinical Trial.

6

Role of radiotherapy in adrenocortical carcinoma.

Ho J, Turkbey B, Edgerly M, Alimchandani M, Quezado M, Camphausen K, Fojo T, Kaushal A. Ho J, et al. Among authors: fojo t. Cancer J. 2013 Jul-Aug;19(4):288-94. doi: 10.1097/PPO.0b013e31829e3221. Cancer J. 2013. PMID: 23867507 Free PMC article.

7

Brain metastasis in patients with adrenocortical carcinoma: a clinical series.

Burotto M, Tageja N, Rosenberg A, Mahalingam S, Quezado M, Velarde M, Edgerly M, Fojo T. Burotto M, et al. Among authors: fojo t. J Clin Endocrinol Metab. 2015 Feb;100(2):331-6. doi: 10.1210/jc.2014-2650. Epub 2014 Nov 20. J Clin Endocrinol Metab. 2015. PMID: 25412413 Free PMC article.

8

Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.

Burotto M, Edgerly M, Poruchynsky M, Velarde M, Wilkerson J, Kotz H, Bates S, Balasubramaniam S, Fojo T. Burotto M, et al. Among authors: fojo t. Oncologist. 2015 Jul;20(7):725-6. doi: 10.1634/theoncologist.2015-0104. Epub 2015 Jun 3. Oncologist. 2015. PMID: 26040622 Free PMC article. Clinical Trial.

9

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Payabyab EC, Balasubramaniam S, Edgerly M, Velarde M, Merino MJ, Venkatesan AM, Leuva H, Litman T, Bates SE, Fojo T. Payabyab EC, et al. Among authors: fojo t. Clin Cancer Res. 2016 Oct 15;22(20):4989-5000. doi: 10.1158/1078-0432.CCR-16-1570. Clin Cancer Res. 2016. PMID: 27742785

10

A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.

Burotto M, Edgerly M, Velarde M, Balasubramaniam S, Drabkin H, Gormaz JG, O'Sullivan C, Madan R, Fojo T. Burotto M, et al. Among authors: fojo t. Oncologist. 2017 Aug;22(8):888-e84. doi: 10.1634/theoncologist.2017-0211. Epub 2017 Jul 5. Oncologist. 2017. PMID: 28679644 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page